1. Acute liver injury induced by drug interaction between dacomitinib and metoprolol due to the inhibition of CYP2D6 by dacomitinib. (June 2023) Authors: Qiu, Xuejia; Ren, Bingnan; Lian, Yufei; Fang, Lingzhi; Dong, Zhanjun Journal: Journal of oncology pharmacy practice Issue: Volume 29:Number 4(2023) Page Start: 1002 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Association between pharmacokinetics of lenvatinib in healthy subjects and genetic polymorphisms of ABCB1 3435C>T and ABCB1 2677G>T/A. (2nd December 2021) Authors: Song, Haojing; Bai, Wanjun; Sun, Xue; Qiu, Bo; Guo, Nini; Guo, Caihui; Hu, Yiting; Dong, Zhanjun Journal: Xenobiotica Issue: Volume 51:Number 12(2021) Page Start: 1463 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Comparative pharmacokinetics of seven bioactive components in normal, sham‐operated, and myocardial ischemia–reperfusion injury rats after oral administration of the Salvia Miltiorrhiza–Moutan Cortex herb pair. (2nd December 2020) Authors: Yang, Haotian; Qiu, Bo; Xue, Chaojun; Guo, Caihui; Dong, Zhanjun Journal: Biomedical chromatography Issue: Volume 35:Number 3(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Determination of atypical antipsychotics in human plasma by UPLC-UV with polystyrene nanofibers as a solid-phase extraction sorbent. Issue 25 (31st May 2022) Authors: Fan, Liju; An, Jing; Gao, Jin; Cui, Yanjun; Dong, Zhanjun Journal: RSC advances Issue: Volume 12:Issue 25(2022) Page Start: 16194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Development, validation, and application of a simple UPLC–MS/MS method for simultaneous quantification of five traditional antipsychotics in human plasma. (6th May 2021) Authors: Fan, Liju; An, Jing; Cui, Yanjun; Dong, Zhanjun Journal: Biomedical chromatography Issue: Volume 35:Number 9(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Effects of voriconazole and fluconazole on the pharmacokinetics of almonertinib in rats by UPLC–MS/MS. (27th October 2022) Authors: Fu, Yuhao; Li, Ying; Ma, Yinling; He, Xueru; Xun, Xuejiao; Cui, Yanjun; Fan, Liju; Dong, Zhanjun Journal: Biomedical chromatography Issue: Volume 37:Number 1(2023) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Evidence‐based guideline for the prevention and management of perioperative infection. Issue 1 (28th February 2023) Authors: Wang, Qiaoyu; Cao, Mingnan; Tao, Hua; Fei, Zhimin; Huang, Xiufeng; Liang, Pixia; Liu, Baiyun; Liu, Jianping; Lu, Xiaoyang; Ma, Penglin; Si, Shuyi; Wang, Shuo; Zhang, Yuewei; Zheng, Yingli; Zang, Lei; Chen, Xiao; Dong, Zhanjun; Ge, Weihong; Guo, Wei; Hu, Xin Journal: Journal of evidence-based medicine Issue: Volume 16:Issue 1(2023) Page Start: 50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Integrating analysis of circular RNA and mRNA expression profiles in doxorubicin induced cardiotoxicity mice. Issue 5 (25th October 2021) Authors: Xing, Xiaoqing; Tan, Zhenzhen; Zhi, Xuran; Sun, Heming; Yang, Jing; Li, Longfei; Liu, Yi; Wang, Lei; Dong, Zhanjun; Guo, Huicai Journal: Journal of applied toxicology Issue: Volume 42:Issue 5(2022) Page Start: 793 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Proton Pump Inhibitors and the Risk of Community-Acquired Pneumonia: An Updated Meta-analysis. Issue 5 (May 2022) Authors: Xun, Xuejiao; Yin, Qifan; Fu, Yuhao; He, Xueru; Dong, Zhanjun Journal: Annals of pharmacotherapy Issue: Volume 56:Issue 5(2022) Page Start: 524 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. QiShenYiQi pills, a Chinese patent medicine, increase bioavailability of atorvastatin by inhibiting Mrp2 expression in rats. (31st December 2022) Authors: Ding, Congyang; Li, Yajing; Li, Xiao; Meng, Lu; Fu, Ran; Wang, Xiaonan; Li, Ying; Ma, Yinling; Dong, Zhanjun Journal: Pharmaceutical biology Issue: Volume 60:Number 1(2022) Page Start: 185 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗